- ACAD Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-8 Filing
ACADIA Pharmaceuticals (ACAD) S-8Registration of securities for employees
Filed: 23 Sep 24, 5:14pm
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial Effective Date | Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward | |||||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||||
Fees to be Paid | 1 | Equity | Common stock, par value $0.0001 per share | Other | 2,400,000 | $16.41 | $39,384,000.00 | $0.0001476 | $5,813.08 | |||||||||||||||||
Fees Previously Paid | ||||||||||||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||||
Total Offering Amounts: | $39,384,000.00 | $5,813.08 | ||||||||||||||||||||||||
Total Fees Previously Paid: | $0.00 | |||||||||||||||||||||||||
Total Fee Offsets: | $0.00 | |||||||||||||||||||||||||
Net Fee Due: | $5,813.08 |
1 | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement also registers any additional shares of the Registrant’s common stock, par value $0.0001 per share (the “Common Stock”), that may become issuable under the Registrant’s 2024 Inducement Plan (the “Inducement Plan”) as a result of any stock split, stock dividend, recapitalization or similar event. |